SIGA Technologies (SIGA) Earnings: Q3 2026 Results

The quarter ended September 30, 2026 and SIGA Technologies published the results on November 9, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison.

• SIGA reports in whole dollars; figures here are rounded to thousands and shown in millions. Its revenue depends on when government orders are delivered, so quarters vary widely: Q2 2026 revenue was $41.0 million and Q3 2026 $1.3 million.
• SIGA declared a special cash dividend of $0.60 per share on March 26, 2026, paid April 23, 2026.

Source: SIGA Technologies Q3 2026 results, November 9, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How SIGA Technologies splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• SIGA Technologies's Product sales and supportive services revenue was $0.2 million in Q3 2026, down 74% from $0.9 million in Q3 2025, 18% of total revenue.
• SIGA Technologies's Research and development revenue was $1.1 million in Q3 2026, down 37% from $1.7 million in Q3 2025, 82% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

GAAP total revenues and diluted earnings (loss) per share, each as first reported in that quarter's release. The Q4 2025 release prints fourth-quarter revenue only rounded ($3.8 million), so that row's revenue is 2025 annual revenue minus nine-month revenue; its EPS of -$0.08 is as printed.

We do not hold a confirmed date for SIGA Technologies's next report. Companies post the date on their investor relations site a few weeks ahead, usually with the time of the conference call.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 9, 2026

SIGA Technologies sells TPOXX (tecovirimat), a smallpox antiviral, mostly to governments for stockpiles. Total revenues were $1,316,965 in Q3 2026, against $2,620,000 a year earlier, because SIGA delivered no product in either quarter: product sales and supportive services were $233,689 and research and development revenue $1,083,276. (SIGA Q3 2026 release, Nov 9, 2026; SIGA Form 10-Q, Q3 2026, Nov 9, 2026)

The $0.2 million of product-line revenue was reimbursed supportive services for a manufacturing technology transfer. Research and development revenue of $1.1 million, against $1.7 million, was earned under the 19C BARDA Contract, the 2018 contract under which SIGA supplies oral and IV TPOXX to the U.S. Strategic National Stockpile. (SIGA Form 10-Q, Q3 2026, Nov 9, 2026)

SIGA's year so far was made in earlier quarters. Nine-month product sales were $41.6 million, against $85.8 million, and included approximately $26 million of IV TPOXX delivered to the Strategic National Stockpile, which fulfilled the final procurement order under the 19C contract, and approximately $13 million of oral TPOXX delivered to two international customers. (SIGA Q3 2026 release, Nov 9, 2026)

With the 19C contract's procurement complete, SIGA is working with the U.S. government on a follow-on contract and says there is no assurance about its timing or terms. Abroad, the Canadian Department of National Defence awarded SIGA a contract in October for up to approximately $15 million of oral TPOXX by March 31, 2031, about $9 million of it firm, and in March 2026 SIGA licensed oral TPOXX to Hikma for the Middle East and North Africa. (SIGA Form 10-Q, Q3 2026, Nov 9, 2026; SIGA Q3 2026 release, Nov 9, 2026)

SIGA Technologies reports GAAP EPS only. Its net loss was $2,893,064, or $0.04 per diluted share, in Q3 2026, against $6,365,819, or $0.09, a year earlier. The operating loss narrowed to $6,520,048 from $10,222,579, mainly because research and development expense fell to $2,639,444 from $7,053,985. (SIGA Q3 2026 release, Nov 9, 2026)

A tax benefit offset part of the pre-tax loss of $5.5 million: SIGA recorded a $2.6 million income tax benefit, an effective rate of 47.2%, against 23.8% a year earlier. Other income, net was $1,037,470, against $1,866,693. (SIGA Form 10-Q, Q3 2026, Nov 9, 2026; SIGA Q3 2026 release, Nov 9, 2026)

The share count barely moves. Diluted weighted average shares were 71,849,132, against 71,604,956. SIGA paid a special cash dividend of $0.60 per share in April 2026. Cash and cash equivalents were $116,380,386 at September 30, 2026, against $154,966,414 at December 31, 2025. (SIGA Q3 2026 release, Nov 9, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

SIGA Technologies does not publish a revenue or earnings outlook in its release. The CEO said SIGA continues to work with the U.S. government toward a new TPOXX procurement contract and is pursuing other international governments to diversify its customer base. (SIGA Q3 2026 release, Nov 9, 2026)

SIGA carried $41,594,073 of inventory at September 30, 2026, against $49,054,873 at year-end 2025. Its 10-Q warns that significant delays in securing a new U.S. contract, or terms different from prior contracts, could materially affect the recoverability of that inventory. (SIGA Q3 2026 release, Nov 9, 2026; SIGA Form 10-Q, Q3 2026, Nov 9, 2026)

A consensus figure is the average of the models published by the analysts who cover SIGA Technologies, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones SIGA Technologies's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning SIGA is on is SIGA a buy or a sell?, what analysts expect next is on the SIGA forecast, and what the company does is on the SIGA Technologies (SIGA) stock page.

Every number on this page can be traced to a document SIGA Technologies published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.